AlphaCentric Advisors »

Day One Biopharmaceuticals I shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $250k 27k 9.32
2023-09-30 $1.2M 95k 12.27
2023-06-30 $1.3M 110k 11.94

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invitation Homes (INVH)
Ishares Tr Mbs Etf (MBB)
Euronet Worldwide (EEFT)
Vertex Pharmaceuticals Incorporated (VRTX)
Astrazeneca Sponsored Adr
Alpine Income Ppty Tr (PINE)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Ionis Pharmaceuticals (IONS)
Stereotaxis Com New (STXS)
Incyte Corporation (INCY)
Insmed Com Par $.01 (INSM)
AMREP Corporation (AXR)
Argenx Se Sponsored Adr (ARGX)

View all positions for AlphaCentric Advisors

Top funds holding Day One Biopharmaceuticals I

FMR
BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
Vestal Point Capital
State Street Corporation
Deerfield Management Company
Pictet Asset Management Holding SA
AIGH Capital Management
Geode Capital Management
Hudson Bay Capital Management
Goldman Sachs Group
Qube Research & Technologies
MAK Capital One
Balyasny Asset Management

View all funds holding Day One Biopharmaceuticals I